Biotech · Private company · Rensselaer, NY, US
NanoPharmaceuticals LLC
Track this companyFree. Adds NanoPharmaceuticals LLC to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- fb-PMTPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Tolerability of Fb-PMT in Recurrent GlioblastomaPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 23, 2022ClinicalTrials.gov NCT05226494 · fetched Nov 12, 2026
NIH awards2
- NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma ManagementFiscal year 2025 · $869.4KNIH RePORTER 5R44CA287485-02 · fetched Nov 12, 2026
- NP855 for Targeting Thyrointegrin αvβ3 receptors and Norepinephrine Transporter in Neuroblastoma ManagementFiscal year 2024 · $792.4KNIH RePORTER 1R44CA287485-01A1 · fetched Nov 12, 2026